About Dr Lal Pathlabs Ltd
Dr. Lal PathLabs engaged in the business of running laboratories for carrying out pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology,
Founded
1995
CEO
Arvind Lal
Employees
5,611
HQ
Gurgaon, India
Finished Products
1Sale of Services
₹12,255.63Cr2Other Operating Revenue
₹0.91CrRaw Materials
1Cost of Materials Consumed
₹2,228.37CrAbout Dr Lal Pathlabs Ltd
Dr. Lal PathLabs engaged in the business of running laboratories for carrying out pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology,
Founded:1995
CEO:Arvind Lal
Employees:5,611
HQ:Gurgaon, India
Finished Products
1Sale of Services
₹12,255.63Cr2Other Operating Revenue
₹0.91CrRaw Materials
1Cost of Materials Consumed
₹2,228.37CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹1,989
52W Low
₹1,273
Volume178.40K
Avg VolumeN/A
Beta0.53
Dividend Yield1.08%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
58.48x
Valuation
P/B Ratio
12.74x
Valuation
EPS
₹32.55
Valuation
Dividend Yield
1.08%
Valuation
ROE
20.13%
Profitability
ROCE
25.56%
Profitability
Revenue by Segment
Contribution & growth by business line
Running laboratories for carrying oRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
99.2%
International
0.8%
India99.2%
Outside India0.8%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.08x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
7.5%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.